Canadian Urological Association guideline: Management of small renal masses - Full-text

Abstract

The incidence of SRM is increasing and many of these incidentally found lesions will be either benign or of low metastatic potential. Immediate invasive treatment of all patients with SRM leads to significant overtreatment. Importantly, most of the evidence on management options for patients with SRM is based on observational data, which are subject to many biases. Thus, most recommendations are based on evidence with low certainty of effect. The panel hopes that in the near future, higher-quality studies will further refine the management of SRM. In the meantime, it is important to obtain a treatment consensus through a shared decision-making approach after weighing the pros and cons of each option according to each patient's own values and preferences.